fig7

Integrative multi-omics analysis for identifying novel therapeutic targets and predicting immunotherapy efficacy in lung adenocarcinoma

Figure 7. Model evaluation of prognostic model MOMLS. (A) Comprehensive clinical nomogram based on MOMLS; (B) The 1, 3, and 5-year forecast curves of the nomogram; (C) Analysis of the decision curve in the nomogram. MOMLS: Multi-omics-driven machine learning signature; TCGA: The Cancer Genome Atlas; RS: risk score.

Cancer Drug Resistance
ISSN 2578-532X (Online)

Portico

All published articles will preserved here permanently:

https://www.portico.org/publishers/oae/

Portico

All published articles will preserved here permanently:

https://www.portico.org/publishers/oae/